suggest that differential methylation at CpG sites in five regions (TXNIP, SOCS3, PHOSPHO1, ABCG1, SREBF1) plays a contributing role to future development of T2D over an 8 year follow up. This evidence concerns the gene SREBF1 and type 2 diabetes mellitus.